182 related articles for article (PubMed ID: 9535920)
1. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing.
Harnish DC; Evans MJ; Scicchitano MS; Bhat RA; Karathanasis SK
J Biol Chem; 1998 Apr; 273(15):9270-8. PubMed ID: 9535920
[TBL] [Abstract][Full Text] [Related]
2. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.
Kilbourne EJ; Evans MJ; Karathanasis SK
Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550
[TBL] [Abstract][Full Text] [Related]
3. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4.
Harnish DC; Malik S; Kilbourne E; Costa R; Karathanasis SK
J Biol Chem; 1996 Jun; 271(23):13621-8. PubMed ID: 8662915
[TBL] [Abstract][Full Text] [Related]
4. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4.
Ginsburg GS; Ozer J; Karathanasis SK
J Clin Invest; 1995 Jul; 96(1):528-38. PubMed ID: 7615825
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
Madak-Erdogan Z; Katzenellenbogen BS
Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
[TBL] [Abstract][Full Text] [Related]
6. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid.
Widom RL; Rhee M; Karathanasis SK
Mol Cell Biol; 1992 Aug; 12(8):3380-9. PubMed ID: 1321332
[TBL] [Abstract][Full Text] [Related]
7. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
Harnish DC; Malik S; Karathanasis SK
J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human apolipoprotein A-I gene expression by gramoxone.
Cuthbert C; Wang Z; Zhang X; Tam SP
J Biol Chem; 1997 Jun; 272(23):14954-60. PubMed ID: 9169468
[TBL] [Abstract][Full Text] [Related]
9. TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4.
Malik S; Karathanasis SK
Mol Cell Biol; 1996 Apr; 16(4):1824-31. PubMed ID: 8657158
[TBL] [Abstract][Full Text] [Related]
10. cis-acting elements and transcription factors involved in the promoter activity of the human factor VIII gene.
Figueiredo MS; Brownlee GG
J Biol Chem; 1995 May; 270(20):11828-38. PubMed ID: 7744832
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of apolipoprotein AI gene expression by orphan receptor ARP-1.
Ge R; Rhee M; Malik S; Karathanasis SK
J Biol Chem; 1994 May; 269(18):13185-92. PubMed ID: 8175747
[TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
Schaufele F
Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the apoAI gene by hepatic nuclear factor 4 in yeast.
Fuernkranz HA; Wang Y; Karathanasis SK; Mak P
Nucleic Acids Res; 1994 Dec; 22(25):5665-71. PubMed ID: 7838720
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor 4 inhibits the activity of site A from the rat apolipoprotein AI gene.
Murao K; Bassyouni H; Taylor AH; Wanke IE; Wong NC
Biochemistry; 1997 Jan; 36(2):301-6. PubMed ID: 9003181
[TBL] [Abstract][Full Text] [Related]
15. Zinc depletion reduced Egr-1 and HNF-3beta expression and apolipoprotein A-I promoter activity in Hep G2 cells.
Cui L; Schoene NW; Zhu L; Fanzo JC; Alshatwi A; Lei KY
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C623-30. PubMed ID: 12107072
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region.
Costa RH; Grayson DR
Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969
[TBL] [Abstract][Full Text] [Related]
17. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression.
Kritis AA; Ktistaki E; Barda D; Zannis VI; Talianidis I
Nucleic Acids Res; 1993 Dec; 21(25):5882-9. PubMed ID: 8290348
[TBL] [Abstract][Full Text] [Related]
18. Sp and GATA factors are critical for Apolipoprotein AI downstream enhancer activity in human HepG2 cells.
Ivanov GS; Kater JM; Jha SH; Stutius EA; Sabharwal R; Tricarico MD; Ginsburg GS; Ozer JS
Gene; 2003 Dec; 323():31-42. PubMed ID: 14659877
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2.
Horani MH; Gobal F; Haas MJ; Wong NC; Mooradian AD
Metabolism; 2004 Feb; 53(2):174-81. PubMed ID: 14767868
[TBL] [Abstract][Full Text] [Related]
20. Cocoa flavanol metabolites activate HNF-3β, Sp1, and NFY-mediated transcription of apolipoprotein AI in human cells.
Oleaga C; Ciudad CJ; Izquierdo-Pulido M; Noé V
Mol Nutr Food Res; 2013 Jun; 57(6):986-95. PubMed ID: 23293065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
